Track the MDXHEALTH stock price and the full directors' dealings record of the company, a publicly traded company based in Belgium. Shares trade on BE BE, under the oversight of FSMA. Market capitalisation: €20.5m. The latest transaction was reported on 13 September 2023 (Purchase). Among the most active insiders: Sollee Joseph. All data is free.
13
Insider Decl.
0
Thresholds
€4m
13 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Buys €4m· Sells
Fundamental score
Ranked 22,628 of 26,063 companies
25.1
score / 100
Value
7
Quality
44
FCF yld-16%
Earn yld-163%
EV/EBITDA·
ROE·
Gross mgn65%
Net mgn-31%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1,000,000 shares@ €1.38100.0% of flowOptions /warrants for employees or managersEuronext BrusselsFSMA:mdxhealth-1
Ideal exit: 10 Apr 2022 (T+270)
13 of 13 declarations
About MDXHEALTH
MDXHEALTH is a company listed on the XBRU market, specializing in the development of diagnostic solutions for cancer. It focuses on improving patient outcomes through innovative testing.